Cefuroxime Axetil for Oral Solution USP 125 mg/5 mL and 250 mg/5 mL
Approved: February 5, 2008 Ranbaxy Pharmaceuticals, Inc.
Generic for: Ceftin for Oral Suspension
Alendronate Sodium Tablets USP, 5 mg (base), 10 mg (base), and 40 mg (base) for Once-Daily Dosing; and 35 mg (base) and 70 mg (base) for Once-Weekly Dosing
Approved: February 6, 2008 Teva Pharmaceuticals USA; Barr Laboratories, Inc. (70 mg Once-Weekly only)
Generic for: Fosamax Tablets
Pramipexole Dihydrochloride Tablets 0.125 mg, 0.25 mg, 0.5 mg, 1 mg, and 1.5 mg
Approved: February 19, 2008 Barr Laboratories, Inc.
Generic for: Mirapex Tablets
Irinotecan Hydrochloride Injection 20 mg/mL; packaged in 40 mg/2 mL and 100 mg/5 mL single-use vials
Approved: February 20, 2008 Watson Laboratories, Inc.
Generic for: Camptosar Injection